REPORT ID 13335

United States Metabotropic Glutamate Receptor Market Report 2017

Publish Date
21-Nov-17
Pages
98
Format
Electronic (PDF)

In this report, the United States Metabotropic Glutamate Receptor market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
    The West
    Southwest
    The Middle Atlantic
    New England
    The South
    The Midwest
with sales (volume), revenue (value), market share and growth rate of Metabotropic Glutamate Receptor in these regions, from 2012 to 2022 (forecast).

United States Metabotropic Glutamate Receptor market competition by top manufacturers/players, with Metabotropic Glutamate Receptor sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    Addex Therapeutics Ltd
    Domain Therapeutics SA
    Medgenics
    Prexton Therapeutics SA
    Taisho Pharmaceutical Holdings
    ...

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    mGluR2
    mGluR4
    mGluR5
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Attention Deficit Hyperactivity Disorder
    Alzheimer's Disease
    Chronic Obstructive Pulmonary Disease

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

United States Metabotropic Glutamate Receptor Market Report 2017
1 Metabotropic Glutamate Receptor Overview
    1.1 Product Overview and Scope of Metabotropic Glutamate Receptor
    1.2 Classification of Metabotropic Glutamate Receptor by Product Category
        1.2.1 United States Metabotropic Glutamate Receptor Market Size (Sales Volume) Comparison by Type (2012-2022)
        1.2.2 United States Metabotropic Glutamate Receptor Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
        1.2.3 mGluR2
        1.2.4 mGluR4
        1.2.5 mGluR5
    1.3 United States Metabotropic Glutamate Receptor Market by Application/End Users
        1.3.1 United States Metabotropic Glutamate Receptor Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
        1.3.2 Attention Deficit Hyperactivity Disorder
        1.3.3 Alzheimer's Disease
        1.3.4 Chronic Obstructive Pulmonary Disease
    1.4 United States Metabotropic Glutamate Receptor Market by Region
        1.4.1 United States Metabotropic Glutamate Receptor Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 The West Metabotropic Glutamate Receptor Status and Prospect (2012-2022)
        1.4.3 Southwest Metabotropic Glutamate Receptor Status and Prospect (2012-2022)
        1.4.4 The Middle Atlantic Metabotropic Glutamate Receptor Status and Prospect (2012-2022)
        1.4.5 New England Metabotropic Glutamate Receptor Status and Prospect (2012-2022)
        1.4.6 The South Metabotropic Glutamate Receptor Status and Prospect (2012-2022)
        1.4.7 The Midwest Metabotropic Glutamate Receptor Status and Prospect (2012-2022)
    1.5 United States Market Size (Value and Volume) of Metabotropic Glutamate Receptor (2012-2022)
        1.5.1 United States Metabotropic Glutamate Receptor Sales and Growth Rate (2012-2022)
        1.5.2 United States Metabotropic Glutamate Receptor Revenue and Growth Rate (2012-2022)

2 United States Metabotropic Glutamate Receptor Market Competition by Players/Suppliers
    2.1 United States Metabotropic Glutamate Receptor Sales and Market Share of Key Players/Suppliers (2012-2017)
    2.2 United States Metabotropic Glutamate Receptor Revenue and Share by Players/Suppliers (2012-2017)
    2.3 United States Metabotropic Glutamate Receptor Average Price by Players/Suppliers (2012-2017)
    2.4 United States Metabotropic Glutamate Receptor Market Competitive Situation and Trends
        2.4.1 United States Metabotropic Glutamate Receptor Market Concentration Rate
        2.4.2 United States Metabotropic Glutamate Receptor Market Share of Top 3 and Top 5 Players/Suppliers
        2.4.3 Mergers & Acquisitions, Expansion in United States Market
    2.5 United States Players/Suppliers Metabotropic Glutamate Receptor Manufacturing Base Distribution, Sales Area, Product Type

3 United States Metabotropic Glutamate Receptor Sales (Volume) and Revenue (Value) by Region (2012-2017)
    3.1 United States Metabotropic Glutamate Receptor Sales and Market Share by Region (2012-2017)
    3.2 United States Metabotropic Glutamate Receptor Revenue and Market Share by Region (2012-2017)
    3.3 United States Metabotropic Glutamate Receptor Price by Region (2012-2017)

4 United States Metabotropic Glutamate Receptor Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
    4.1 United States Metabotropic Glutamate Receptor Sales and Market Share by Type (Product Category) (2012-2017)
    4.2 United States Metabotropic Glutamate Receptor Revenue and Market Share by Type (2012-2017)
    4.3 United States Metabotropic Glutamate Receptor Price by Type (2012-2017)
    4.4 United States Metabotropic Glutamate Receptor Sales Growth Rate by Type (2012-2017)

5 United States Metabotropic Glutamate Receptor Sales (Volume) by Application (2012-2017)
    5.1 United States Metabotropic Glutamate Receptor Sales and Market Share by Application (2012-2017)
    5.2 United States Metabotropic Glutamate Receptor Sales Growth Rate by Application (2012-2017)
    5.3 Market Drivers and Opportunities

6  United States Metabotropic Glutamate Receptor Players/Suppliers Profiles and Sales Data
    6.1 Addex Therapeutics Ltd
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Metabotropic Glutamate Receptor Product Category, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Addex Therapeutics Ltd Metabotropic Glutamate Receptor Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Domain Therapeutics SA
        6.2.2 Metabotropic Glutamate Receptor Product Category, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Domain Therapeutics SA Metabotropic Glutamate Receptor Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Medgenics
        6.3.2 Metabotropic Glutamate Receptor Product Category, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Medgenics Metabotropic Glutamate Receptor Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Prexton Therapeutics SA
        6.4.2 Metabotropic Glutamate Receptor Product Category, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Prexton Therapeutics SA Metabotropic Glutamate Receptor Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 Taisho Pharmaceutical Holdings
        6.5.2 Metabotropic Glutamate Receptor Product Category, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Taisho Pharmaceutical Holdings Metabotropic Glutamate Receptor Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    ...

7 Metabotropic Glutamate Receptor Manufacturing Cost Analysis
    7.1 Metabotropic Glutamate Receptor Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Metabotropic Glutamate Receptor

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Metabotropic Glutamate Receptor Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Metabotropic Glutamate Receptor Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 United States Metabotropic Glutamate Receptor Market Size (Value and Volume) Forecast (2017-2022)
    11.1 United States Metabotropic Glutamate Receptor Sales Volume, Revenue Forecast (2017-2022)
    11.2 United States Metabotropic Glutamate Receptor Sales Volume Forecast by Type (2017-2022)
    11.3 United States Metabotropic Glutamate Receptor Sales Volume Forecast by Application (2017-2022)
    11.4 United States Metabotropic Glutamate Receptor Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer